Skip to Main Content

Paper Details

Preclinical In Vivo Validation of the RAD51 Test for Identification of Homologous Recombination-Deficient Tumors and Patient Stratification.
Cancer Res
32
2022
Author NameAffiliation
Carlos CaldasCancer Research UK Cambridge Institute and Department of Oncology, University of Cambridge
Carlos CaldasCancer Research UK (CRUK) Cambridge Cancer Centre
Serena Nik-ZainalUniversity of Cambridge
Serena Nik-ZainalHutchison/MRC Research Centre, University of Cambridge
Joaquin MateoVall d'Hebron University Hospital, Autonomous University of Barcelona
Joaquin MateoVall d'Hebron Institut d'Oncologia
Rodrigo DienstmannVall d'Hebron Institute of Oncology
  • 1 - 7

Datasets

Release 1.2